Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain

The emerging new lineages of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have marked a new phase of coronavirus disease 2019 (COVID-19). Understanding the recognition mechanisms of potent neutralizing monoclonal antibodies (NAbs) against the spike protein is pivotal for developing n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mei, Li, Jiaqi, Huang, Zhaoxia, Li, Heng, Wang, Yueming, Wang, Xiaoli, Kang, Sisi, Huang, Xing, Wu, Changwen, Liu, Tong, Jia, Zhenxing, Liang, Junlang, Yuan, Xiaohui, He, Suhua, Chen, Xiaoxue, Zhou, Zhechong, Chen, Qiuyue, Liu, Siqi, Li, Jing, Zheng, Huiwen, Liu, Xi, Li, Kenan, Yao, Xiaojun, Lang, Bin, Liu, Longding, Liao, Hua-Xin, Chen, Shoudeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515945/
https://www.ncbi.nlm.nih.gov/pubmed/34643438
http://dx.doi.org/10.1128/Spectrum.01352-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515945/
https://www.ncbi.nlm.nih.gov/pubmed/34643438
http://dx.doi.org/10.1128/Spectrum.01352-21

Ejemplares similares